---
layout: post
title: "Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products: Questions and Answers; Revised Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request"
date: 2026-02-05 18:57:18 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-23372
original_published: 2023-10-24 00:00:00 +0000
significance: 8.00
---

# Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products: Questions and Answers; Revised Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request

**Published:** February 05, 2026 18:57 UTC
**Source:** Federal Register
**Original Published:** October 24, 2023 00:00 UTC
**Document Number:** 2023-23372

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a revised draft guidance for industry entitled "Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products: Questions and Answers." This revised draft guidance, when finalized, will provide FDA's current thinking on common questions regarding certain communications by firms to health care providers (HCPs) of scientific information on unapproved use(s) of approved/ cleared medical products (the scope of the italicized terms is further explained in the revised draft guidance). This revised guidance supersedes the revised draft guidance entitled "Distributing Scientific and Medical Publications on Unapproved New Uses--Recommended Practices" issued in 2014 (2014 revised draft guidance).

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/10/24/2023-23372/communications-from-firms-to-health-care-providers-regarding-scientific-information-on-unapproved)
- API: https://www.federalregister.gov/api/v1/documents/2023-23372

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
